Nevertheless, no inhibitor has yet reached phase I clinical trials and further efforts are needed to circumvent all obstacles related to absorption, metabolism and various issues on pharmacokinetics in order to eventually achieve orally bioavailable drug candidates acting as cognitive enhancers in vivo
The insulin-regulated aminopeptidase a companion and regulator of GLUT4
In controlled laboratory settings, Epitalon is widely researched for telomerase pathway activation, endocrine-signalling balance, melatonin-regulation studies, and cellular repair modelling
doi: 10.1210/endrev/bnab022
It may also appeal to people looking for targeted gut and connective tissue support without gluten, soy, dairy, preservatives, or synthetic dyes
What the Current Research Does Not Establish The existing research base does not establish BPC-157 as clinically proven in humans for any specific application the vast majority of studies are pre-clinical, and extrapolating animal-model findings to human outcomes is not scientifically appropriate without human clinical data
